Change - Announcement of Cessation::CESSATION OF CHIEF OPERATING OFFICER

Issuer & Securities

Issuer/ Manager
OUE LIPPO HEALTHCARE LIMITED
Securities
OUE LIPPO HEALTHCARE LTD - SG2F86994413 - 5WA
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
08-Mar-2023 22:00:34
Status
New
Announcement Sub Title
CESSATION OF CHIEF OPERATING OFFICER
Announcement Reference
SG230308OTHRPROR
Submitted By (Co./ Ind. Name)
Mr Yet Kum Meng
Designation
Chief Executive Officer and Executive Director
Description (Please provide a detailed description of the event in the box below)
Cessation of Chief Operating Officer.

This announcement has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this document, including the correctness of any of the statements or opinions made or reports contained in this document.

The contact person for the Sponsor is Ms. Foo Jien Jieng, 16 Collyer Quay, #10-00 Collyer Quay Centre, Singapore 049318, sponsorship@ppcf.com.sg.

Additional Details

Name Of Person
Joelle Lee Siew Hong
Age
51
Is effective date of cessation known?
Yes
If yes, please provide the date
05/06/2023
Detailed Reason (s) for cessation
Ms. Joelle Lee Siew Hong ("Ms. Joelle") had, on 6 March 2023, tendered her resignation as Chief Operating Officer of OUE Lippo Healthcare Limited (the "Company" and together with its subsidiaries, the "Group"), due to personal interests. Ms. Joelle's last day of service with the Company will be 5 June 2023. Upon Ms. Joelle's last day of service, she will be engaged as a Consultant for a period of 3 months from 6 June 2023 to 5 September 2023 to ensure a smooth transition of the Group's overall operations.

In addition, the Company confirms that there are no concerns with regards to the overall operations of the Group that led to the cessation of Ms. Joelle as the Chief Operating Officer and there are no disagreements between Ms. Joelle and the Board of Directors (the "Board") of the Company with regards to practices that would have an impact to the Group's overall operations.

After having interviewed Ms. Joelle and to the best of its knowledge, the Company's Sponsor, PrimePartners Corporate Finance Pte. Ltd., is satisfied that save as disclosed in this announcement, there are no other material reasons for the cessation of Ms. Joelle as the Chief Operating Officer of the Company.

The Company is in the process of finding a suitable replacement and will make the necessary announcement when a suitable candidate is appointed.

The Board would like to extend its gratitude and appreciation to Ms. Joelle for her invaluable contributions to the Company during her tenure of service.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
03/01/2022
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
3
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
1
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Operating Officer
Role and responsibilities
Responsible for the Group's overall operations.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Nil
Shareholding interest in the listed issuer and its subsidiaries?
No
Past (for the last 5 years)
Refer to Appendix A
Present
Refer to Appendix B

Attachments

Appendix A - Past 5 years Directorships.pdf
Appendix B - Present Directorships.pdf
Total size =394K